CoChat

Treatment with α-Galactosylceramide Attenuates the Development of Bleomycin-Induced Pulmonary Fibrosis

Open access
Kimura, Toru, Ishii, Yukio, Morishima, Yuko, Shibuya, Akira, Shibuya, Kazuko, Taniguchi, Masaru, Mochizuki, Mie, Hegab, Ahmed E, Sakamoto, Tohru, Nomura, Akihiro, Sekizawa, Kiyohisa · 2004 · The Journal of Immunology
Cited by 43

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Pulmonary fibrosis is an end-stage disorder for which efficacious therapeutic options are not readily available. Although its pathogenesis is poorly understood, pulmonary fibrosis occurs as a result of various inflammations. NKT cells modulate inflammation because of their ability to produce large amounts of cytokines by stimulation with their glycolipid ligand. In the present study, we investigated the effects of α-galactosylceramide (α-GalCer), a selective NKT cell ligand, on the development of bleomycin-induced pulmonary fibrosis. Treatment of mice with α-GalCer prolonged their survival under bleomycin administration by attenuating the development of pulmonary fibrosis. The protective effects of α-GalCer were associated with an increase in the pulmonary level of IFN-γ and a decrease in the pulmonary level of fibrogenic cytokines such as TGF-β and connective tissue growth factor. The initial pulmonary inflammation caused by bleomycin was also attenuated by α-GalCer with the reduction of the macrophage inflammatory protein-2 level. The protective effects of α-GalCer were markedly reduced in mice lacking NKT cells or as a result of treatment with anti-IFN-γ Ab. These results suggest that α-GalCer suppresses bleomycin-induced acute pulmonary inflammation and thus attenuates the development of pulmonary fibrosis possibly by regulating several cytokine levels.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.172.9.5782

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

Metadata

Authors
Kimura, T., Ishii, Y., Morishima, Y., Shibuya, A., Shibuya, K., Taniguchi, M., Mochizuki, M., Hegab, A. E., Sakamoto, T., Nomura, A., & Sekizawa, K.
Venue
The Journal of Immunology
Published
2004-05-01
Volume
172
Issue
9
Pages
5782-5789
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W2121836556
Cited by
43
References
5
FWCI
2.86
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.